Ferroptosis in Cardiovascular Diseases and Ferroptosis-Related Intervention Approaches

Overview

Journal Cardiovasc Drugs Ther

Specialties Cardiology & Vascular Diseases
Pharmacology

Date 2024 Dec 6

PMID 39641901

Authors

Xianpeng Zhou

Hao Wang

Biao Yan

Xinwen Nie

Qingjie Chen

Xiaosong Yang

Min Lei

Xiying Guo

Changhan Ouyang

Zhanhong Ren

Affiliations

Soon will be listed here.

Abstract

Objective: Cardiovascular diseases (CVDs) are major public health problems that threaten the lives and health of individuals. The article has reviewed recent progresses about ferroptosis and ferroptosis-related intervention approaches for the treatment of CVDs and provided more references and strategies for targeting ferroptosis to prevent and treat CVDs.

Methods: A comprehensive review was conducted using the literature researches.

Results And Discussion: Many ferroptosis-targeted compounds and ferroptosis-related genes may be prospective targets for treating CVDs and our review provides a solid foundation for further studies about the detailed pathological mechanisms of CVDs.

Conclusion: There are challenges and limitations about the translation of ferroptosis-targeted potential therapies from experimental research to clinical practice. It warrants further exploration to pursure safer and more effective ferroptosis-targeted thereapeutic approaches for CVDs.

References

Mensah G, Fuster V, Roth G . A Heart-Healthy and Stroke-Free World: Using Data to Inform Global Action. J Am Coll Cardiol. 2023; 82(25):2343-2349. DOI: 10.1016/j.jacc.2023.11.003. View

Li Z, Lin L, Wu H, Yan L, Wang H, Yang H . Global, Regional, and National Death, and Disability-Adjusted Life-Years (DALYs) for Cardiovascular Disease in 2017 and Trends and Risk Analysis From 1990 to 2017 Using the Global Burden of Disease Study and Implications for Prevention. Front Public Health. 2021; 9:559751. PMC: 8589040. DOI: 10.3389/fpubh.2021.559751. View

Adhikary D, Barman S, Ranjan R, Stone H . A Systematic Review of Major Cardiovascular Risk Factors: A Growing Global Health Concern. Cureus. 2022; 14(10):e30119. PMC: 9644238. DOI: 10.7759/cureus.30119. View

Arnett D, Blumenthal R, Albert M, Buroker A, Goldberger Z, Hahn E . 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019; 140(11):e596-e646. PMC: 7734661. DOI: 10.1161/CIR.0000000000000678. View

Mozaffarian D, Benjamin E, Go A, Arnett D, Blaha M, Cushman M . Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2015; 133(4):e38-360. DOI: 10.1161/CIR.0000000000000350. View

Del Re D, Amgalan D, Linkermann A, Liu Q, Kitsis R . Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease. Physiol Rev. 2019; 99(4):1765-1817. PMC: 6890986. DOI: 10.1152/physrev.00022.2018. View

Bravo-San Pedro J, Kroemer G, Galluzzi L . Autophagy and Mitophagy in Cardiovascular Disease. Circ Res. 2017; 120(11):1812-1824. DOI: 10.1161/CIRCRESAHA.117.311082. View

Li P, Dong X, Zhang B, Zhang X, Liu J, Ma D . Molecular mechanism and therapeutic targeting of necrosis, apoptosis, pyroptosis, and autophagy in cardiovascular disease. Chin Med J (Engl). 2021; 134(22):2647-2655. PMC: 8631411. DOI: 10.1097/CM9.0000000000001772. View

Zhaolin Z, Guohua L, Shiyuan W, Zuo W . Role of pyroptosis in cardiovascular disease. Cell Prolif. 2018; 52(2):e12563. PMC: 6496801. DOI: 10.1111/cpr.12563. View

10.

Galluzzi L, Vitale I, Aaronson S, Abrams J, Adam D, Agostinis P . Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018; 25(3):486-541. PMC: 5864239. DOI: 10.1038/s41418-017-0012-4. View

11.

Dang X, Huan X, Du X, Chen X, Bi M, Yan C . Correlation of Ferroptosis and Other Types of Cell Death in Neurodegenerative Diseases. Neurosci Bull. 2022; 38(8):938-952. PMC: 9352832. DOI: 10.1007/s12264-022-00861-6. View

12.

Jiang L, Kon N, Li T, Wang S, Su T, Hibshoosh H . Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015; 520(7545):57-62. PMC: 4455927. DOI: 10.1038/nature14344. View

13.

Zhou Y, Liao J, Mei Z, Liu X, Ge J . Insight into Crosstalk between Ferroptosis and Necroptosis: Novel Therapeutics in Ischemic Stroke. Oxid Med Cell Longev. 2021; 2021:9991001. PMC: 8257382. DOI: 10.1155/2021/9991001. View

14.

Tang J, Di J, Cao H, Bai J, Zheng J . p53-mediated autophagic regulation: A prospective strategy for cancer therapy. Cancer Lett. 2015; 363(2):101-7. DOI: 10.1016/j.canlet.2015.04.014. View

15.

Tasdemir E, Maiuri M, Galluzzi L, Vitale I, Djavaheri-Mergny M, DAmelio M . Regulation of autophagy by cytoplasmic p53. Nat Cell Biol. 2008; 10(6):676-87. PMC: 2676564. DOI: 10.1038/ncb1730. View

16.

Tomita Y, Marchenko N, Erster S, Nemajerova A, Dehner A, Klein C . WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization. J Biol Chem. 2006; 281(13):8600-6. DOI: 10.1074/jbc.M507611200. View

17.

Wang H, Shu L, Lv C, Liu N, Long Y, Peng X . BRCC36 Deubiquitinates HMGCR to Regulate the Interplay Between Ferroptosis and Pyroptosis. Adv Sci (Weinh). 2024; 11(11):e2304263. PMC: 10953584. DOI: 10.1002/advs.202304263. View

18.

Lee S, Hwang N, Seok B, Lee S, Lee S, Chung S . Autophagy mediates an amplification loop during ferroptosis. Cell Death Dis. 2023; 14(7):464. PMC: 10368698. DOI: 10.1038/s41419-023-05978-8. View

19.

Wu P, Zhang X, Duan D, Zhao L . Organelle-Specific Mechanisms in Crosstalk between Apoptosis and Ferroptosis. Oxid Med Cell Longev. 2023; 2023:3400147. PMC: 9836800. DOI: 10.1155/2023/3400147. View

20.

Dixon S, Lemberg K, Lamprecht M, Skouta R, Zaitsev E, Gleason C . Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012; 149(5):1060-72. PMC: 3367386. DOI: 10.1016/j.cell.2012.03.042. View